Insider Trading Alert - OHI, SAM, DAL, EXPR And UVV Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 13, 2013, 169 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $704.00 to $43,077,002,500.00.

Highlighted Stocks Traded by Insiders:

Omega Healthcare Investors (OHI) - FREE Research Report

Korman Bernard J who is Director at Omega Healthcare Investors bought 46,070 shares at $31.15 on Nov. 13, 2013. Following this transaction, the Director owned 576,526 shares meaning that the stake was reduced by 8.68% with the 46,070 share transaction.

The shares most recently traded at $32.21, up $1.06, or 3.29% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 9,975

The average volume for Omega Healthcare Investors has been 1.1 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $3.9 billion and is part of the financial sector and real estate industry. Shares are up 32.12% year to date as of the close of trading on Tuesday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 6.09%. The company has a P/E ratio of 22.7. Currently there is 1 analyst that rates Omega Healthcare Investors a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Boston Beer Company (SAM) - FREE Research Report

Koch C James who is Chairman at Boston Beer Company sold 2,000 shares at $241.12 on Nov. 13, 2013. Following this transaction, the Chairman owned 23,864 shares meaning that the stake was reduced by 7.73% with the 2,000 share transaction.

The shares most recently traded at $242.94, up $1.82, or 0.75% since the insider transaction. Historical insider transactions for Boston Beer Company go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 18,550

The average volume for Boston Beer Company has been 49,500 shares per day over the past 30 days. Shares are up 80.15% year to date as of the close of trading on Tuesday.

The Boston Beer Company, Inc. engages in the production and sale of alcohol beverages primarily in the United States, Canada, Europe, Israel, the Caribbean, the Pacific Rim, and Mexico. The company has a P/E ratio of 47.4. Currently there is 1 analyst that rates Boston Beer Company a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SAM - FREE

TheStreet Quant Ratings rates Boston Beer Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Boston Beer Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Delta Air Lines (DAL) - FREE Research Report

Jacobson Paul A who is Evp & Cfo at Delta Air Lines sold 20,000 shares at $28.01 on Nov. 13, 2013. Following this transaction, the Evp & Cfo owned 241,817 shares meaning that the stake was reduced by 7.64% with the 20,000 share transaction.

The shares most recently traded at $27.79, down $0.22, or 0.78% since the insider transaction. Historical insider transactions for Delta Air Lines go as follows:

  • 4-Week # shares bought: 4,000
  • 4-Week # shares sold: 356,053
  • 12-Week # shares bought: 9,000
  • 12-Week # shares sold: 395,349
  • 24-Week # shares bought: 24,000
  • 24-Week # shares sold: 523,227

The average volume for Delta Air Lines has been 17.6 million shares per day over the past 30 days. Delta Air Lines has a market cap of $23.5 billion and is part of the services sector and transportation industry. Shares are up 131.42% year to date as of the close of trading on Tuesday.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. Its route network is centered around a system of hub and international gateway airports in Amsterdam, Atlanta, Cincinnati, Detroit, Memphis, Minneapolis-St. The stock currently has a dividend yield of 0.87%. The company has a P/E ratio of 11.4. Currently there are 7 analysts that rate Delta Air Lines a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DAL - FREE

TheStreet Quant Ratings rates Delta Air Lines as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, solid stock price performance, impressive record of earnings per share growth and revenue growth. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Delta Air Lines Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Express (EXPR) - FREE Research Report

Moellering Matthew C who is EVP & Chief Operating Officer at Express sold 8,571 shares at $24.27 on Nov. 13, 2013. Following this transaction, the EVP & Chief Operating Officer owned 188,359 shares meaning that the stake was reduced by 4.35% with the 8,571 share transaction.

The shares most recently traded at $24.58, up $0.31, or 1.26% since the insider transaction. Historical insider transactions for Express go as follows:

  • 4-Week # shares sold: 14,571
  • 12-Week # shares sold: 129,377
  • 24-Week # shares sold: 476,685

The average volume for Express has been 1.0 million shares per day over the past 30 days. Express has a market cap of $2.0 billion and is part of the services sector and retail industry. Shares are up 58.38% year to date as of the close of trading on Tuesday.

Express, Inc. operates as a specialty apparel and accessory retailer primarily in the United States. Its stores provide apparel and accessories for women and men between 20 and 30 years old across various aspects of the lifestyles comprising work, casual, jeanswear, and going-out occasions. The company has a P/E ratio of 15.6. Currently there are 8 analysts that rate Express a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EXPR - FREE

TheStreet Quant Ratings rates Express as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Universal Corporation (UVV) - FREE Research Report

Adams John B Jr who is Director at Universal Corporation sold 300 shares at $50.68 on Nov. 13, 2013. Following this transaction, the Director owned 18,398 shares meaning that the stake was reduced by 1.6% with the 300 share transaction.

The shares most recently traded at $51.48, up $0.80, or 1.55% since the insider transaction. Historical insider transactions for Universal Corporation go as follows:

  • 4-Week # shares sold: 1,425
  • 12-Week # shares sold: 2,350
  • 24-Week # shares sold: 23,036

The average volume for Universal Corporation has been 208,600 shares per day over the past 30 days. Shares are up 1.54% year to date as of the close of trading on Tuesday.

Universal Corporation, through its subsidiaries, operates as a leaf tobacco merchant and processor worldwide. It engages in selecting, procuring, processing, packing, storing, shipping, and financing leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products. The stock currently has a dividend yield of 4.02%. The company has a P/E ratio of 9.9. Currently there is 1 analyst that rates Universal Corporation a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UVV - FREE

TheStreet Quant Ratings rates Universal Corporation as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, poor profit margins and weak operating cash flow. Get the full Universal Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%